These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 86800)

  • 21. Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature.
    van Seters AP; Bots GT; van Dulken H; Luyendijk W; Vielvoye GJ
    Neurosurgery; 1985 Jun; 16(6):813-7. PubMed ID: 2989726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Bilbao I; Egaña N; García C; Olaizola I
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
    [No Abstract]   [Full Text] [Related]  

  • 23. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
    Canales ES; García IC; Ruíz JE; Zárate A
    Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
    [No Abstract]   [Full Text] [Related]  

  • 24. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
    Ayers JW
    Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
    Kolodny J; Dluhy RG
    Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells.
    Landolt AM; Osterwalder V; Landolt TA
    Experientia; 1985 May; 41(5):640-2. PubMed ID: 3996537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma].
    Geyer G
    Wien Med Wochenschr; 1980 Aug; 130(15-16):501-9. PubMed ID: 6258331
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
    Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M
    No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth and puberty arrest due to prolactinoma.
    Sack J; Friedman E; Tadmor R; Sahar A; Katznelson D
    Acta Paediatr Scand; 1984 Nov; 73(6):863-7. PubMed ID: 6524373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prolactin-producing pituitary adenomas as a cause of primary amenorrhea and their neurosurgical treatment].
    Landolt AM
    Dtsch Med Wochenschr; 1983 Feb; 108(8):298-301. PubMed ID: 6825603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect rates of different modalities for treatment of prolactin adenomas.
    Wollesen F; Bendsen BB
    Am J Med; 1985 Jan; 78(1):114-22. PubMed ID: 3881020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromocriptine therapy for "nonfunctioning" pituitary tumors.
    Johnston DG; Hall K; McGregor A; Ross WM; Kendall-Taylor P; Hall R
    Am J Med; 1981 Dec; 71(6):1059-61. PubMed ID: 7315851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactinoma presenting as painful postganglionic Horner syndrome.
    Talkad AV; Kattah JC; Xu MY; Orth EH; Chang JY
    Neurology; 2004 Apr; 62(8):1440-1. PubMed ID: 15111696
    [No Abstract]   [Full Text] [Related]  

  • 37. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.